granted
on 14 Mar 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
90710139 filed on 13th May 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
FOR BLAZING Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90710139
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
15th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
14th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
14th Mar 2024 | SOU EXTENSION 3 FILED |
14th Mar 2024 | SOU EXTENSION 3 GRANTED |
13th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
11th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
11th Oct 2023 | SOU EXTENSION 2 FILED |
11th Oct 2023 | SOU EXTENSION 2 GRANTED |
08th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
06th Apr 2023 | SOU TEAS EXTENSION RECEIVED |